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Cysteine replacement of Asp190, Glu192 and Ser201 residues in the cytoplasmic interdomain
loop of the TetA(B) tetracycline efflux antiporter from Tn10 reduces tetracycline resistance [Tamura,
N., Konishi, S., Iwaki, S., Kimura-Someya, T., Nada, S. & Yamaguchi, A. (2001). J Biol Chem
276, 20330–20339]. It was found that these Cys substitutions altered the substrate specificity
of TetA(B), increasing the relative resistance to doxycycline and minocycline over that to
tetracycline by three- to sixfold. Substitutions of Asp190 and Glu192 by Ala, Asn and Gln also
impaired the ability of TetA(B) to mediate tetracycline resistance while Ser201Ala and Ser201Thr
substitutions did not. A Leu9Phe substitution in the first transmembrane helix of TetA(B)
suppressed the Ser201Cys mutation, undoing the alterations in resistance and specificity. That
the interdomain loop might contact substrate during transport, as is suggested from its role in
substrate specificity, is unexpected considering that the primary sequence in the loop is not
conserved among a group of otherwise homologous TetA proteins. However, in the interdomain
loop of 11 of 14 homologous TetA efflux proteins, computational analysis revealed a short
a-helix, which includes some residues affecting activity and substrate specificity. Perhaps this
conserved secondary structure accounts for the role of the non-conserved interdomain loop in
TetA function.
INTRODUCTION
The tetracyclines are a family of broad-spectrum antibiotics,
first introduced in 1948, which inhibit protein synthesis by
binding to the 30S ribosomal subunit (Brodersen et al.,
2000; Chopra & Roberts, 2001). TetA(B) is a 401 aa cyto-
plasmic membrane protein belonging to the major facili-
tator superfamily (Pao et al., 1998; Saier et al., 1999). It
maintains intracellular tetracycline concentrations below
growth-inhibitory levels via the energy-dependent efflux of
tetracyclines from bacterial cells, mediated by the trans-
membrane (TM) proton motive force (McMurry et al.,
1980). The membrane topology of TetA(B) has been studied
by proteolysis (Eckert & Beck, 1989), chemical labelling
(Kimura et al., 1996; Yamaguchi et al., 1992a), gene fusion
(Hickman & Levy, 1988) and its percentage a-helix
was calculated from circular dichroism spectral analysis
(Aldema et al., 1996). Based on these studies and hydropathy
analysis, the protein is predicted to have 12 TM a-helices
and is divided into two halves, a and b, by a large puta-
tive cytoplasmic loop designated the interdomain region
(Fig. 1). The a and b domains of the protein (N-terminal
and C-terminal halves, respectively) have presumably
evolved from a duplication of a single domain (Rubin
et al., 1990). The group 1 set of related classes of tetracycline
resistance determinants, A-E, G, H, J, Y, Z, 30, 31 and 33, all
have an efflux pump, TetA, and a divergently transcribed
repressor, TetR (Guillaume et al., 2004; McMurry & Levy,
2000). These homologous TetA proteins have 45–75%
identity. Hybrid interclass Tet protein constructions
(Rubin & Levy, 1990), complementation studies (Curiale
et al., 1984) and second-site suppressor studies (Saraceni-
Richards & Levy, 2000a, b) showed that interactions
between both domains are required for TetA function.
Complete cysteine-scanning mutagenesis of the class B
TetA(B) (Tamura et al., 2001) has revealed that a total of
58 (14%) of the 401 aa contribute to its structure and/or
function. Among them, 17 residues, mostly glycine and
proline, are considered to be essential, whereas the other 41
affect the tetracycline resistance phenotype mediated by
TetA(B) only moderately. In addition, the cysteine-scanning
data indicated the presence of a putative TM water-filled
channel in the transporter. Of the 12 TMs, four (TM3, TM6,
TM9 and TM12) do not face the channel, four (TM2, TM5,
TM8 and TM11) face it along their full-length and the four
remaining (TM1, TM4, TM7 and TM10) contribute by only
half of their length to the side of it while their second half is
embedded in a hydrophobic region (Tamura et al., 2001).Abbreviation: TM, transmembrane.
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The interdomain loop is not conserved among the differ-
ent classes of tetracycline efflux proteins, but appears
nevertheless to be somehow involved in TetA function.
Four mutations, Asp190Cys, Glu192Cys, Ser201Cys and
Met210Cys, within the interdomain loop of the class B TetA,
caused greatly reduced (8- to 32-fold) tetracycline resis-
tance levels without altering the amount of TetA protein
(Kimura et al., 1997; Tamura et al., 2001). In TetA(A),
alteration of three adjacent amino acids (residues 201–203)
in the interdomain loop changed the substrate speci-
ficity, increasing resistance to minocycline and glycyl-
cyclines (Tuckman et al., 2000). The insertion of five
residues (between Arg190 and Pro191) which lengthened
the TetA(C) interdomain loop increased tetracycline sus-
ceptibility (Jewell et al., 1999). In TetA(C), the interdomain
mutation Ser202Phe led to a 12-fold decrease in activity
(Saraceni-Richards & Levy, 2000a); second-site suppressor
mutations which restored resistance were found in TM1,
in the interdomain loop and in the cytoplasmic loop
connecting TM8 and TM9 (Sapunaric & Levy, 2003). To
examine further the role of the interdomain loop of
TetA(B) in substrate specificity, we performed site-directed
mutagenesis at Asp190, Glu192 and Ser201, and assayed
resistance to tetracycline and tetracycline analogues. We
also applied computational analysis to the interdomain
loop to understand why that non-conserved region might
be involved in TetA function.
METHODS
Chemicals. Restriction enzymes were obtained from New England
Biolabs. Pfu DNA polymerase and T4 DNA ligase were purchased
from Stratagene and Invitrogen, respectively. Antibiotics were
obtained from Sigma. 9-(t-butylglycylamido)-minocycline (a glycyl-
cycline) and 5a,6-anhydrotetracycline were gifts from Paratek Phar-
maceuticals. All other materials were reagent grade and obtained
from commercial sources.
Bacterial strains and plasmids. Escherichia coli DH5a (Woodcock
et al., 1989) was the host strain used for all cloning experiments and
propagation of plasmid DNA. Cell cultures were grown at 37 uC in
Luria–Bertani broth (Seoane et al., 1992) supplemented with 20 mg
chloramphenicol ml21 and 30 mg kanamycin ml21 as needed. Fifteen
nanograms of 5a,6-anhydrotetracycline ml21 was used as a gratuitous
inducer of Tet protein where applicable (Moyed et al., 1983).
Low-copy-number plasmids pLGT2 [wild-type tetA(B), origin of repli-
cation pSC101] (Yamaguchi et al., 1990c) and its derivative pLGTS201C
[Ser201Cys mutant of TetA(B)] (Kimura et al., 1997) were kindly
provided by A. Yamaguchi as were other plasmids (see text). All plas-
mids used during this work possess the TetB determinant comprising
both TetR (repressor) and TetA (efflux pump). The TetB determinant
isolated from pLGT2 by BglII/BamHI enzymic restriction was cloned
into the medium-copy-number plasmid pMCL210, origin of replication
p15A (Nakano et al., 1995), to produce transitional plasmid pMCL-
WT-TetB, ready to use as template for site-directed mutagenesis.
Site-directed mutagenesis and nucleotide sequencing. Site-
directed mutagenesis of tetA(B) on plasmid pMCL-WT-TetB
was performed by adaptation of a PCR overlap method (Deng &
Nickoloff, 1992; Wang & Malcom, 1999). Mutagenic PCR primers
were designed to incorporate a restriction endonuclease site along
with the desired mutation where possible (Table 1). Once the muta-
tion was confirmed by restriction enzyme analysis and sequencing,
the fragment was exchanged from the mutagenized plasmid into
the low-copy-number unmutagenized pLGT2 plasmid (Yamaguchi
et al., 1990c). The restriction enzymes used to exchange the frag-
ments were (i) EcoRV/EcoRI for Asp190 and Glu192 substitutions,
(ii) EcoRV/BamHI for Ser201 substitutions, and (iii) EcoRV/XbaI for
the Leu9Phe substitution.
DNA sequencing was performed at the Tufts University Core Facility
using a ABI3100 Genetic Analyser.
Determination of susceptibility to tetracycline and tetra-
cycline analogues. E. coli DH5a cells with and without plasmids
bearing wild-type and tetA(B) mutated genes were grown overnight
in the presence of 25 mg kanamycin ml21 on Mueller–Hinton agar
plates. Cells were swabbed for confluent growth onto a Mueller–
Hinton agar before the application of doxycycline, minocycline and
tetracycline E-test strips (gift from AB Biodisk). The minimum inhi-
bitory concentration (MIC) was that amount of the tetracycline
showing an inhibition growth zone with the E-test after 24 h of
incubation at 37 uC.
Western blot analysis. DH5a cells expressing various plasmid-
specified TetA proteins were grown in the presence of 15 ng 5a,6-
anhydrotetracycline ml21 and rapidly chilled when they reached the
late exponential growth phase (OD550=0?8). Cells were resuspended
at an OD550 of 80 in 20 mM Tris/HCl (pH 8), 2 mM MgCl2, 1 mM
EDTA and 30 mg lysozyme ml21 and disrupted by sonication
(Branson Sonifier 250; Branson Ultrasonics). Total-cell lysate was
used for immunological detection. Proteins were incubated in reduc-
ing sample buffer (Sambrook & Russell, 2001) for 20 min at room
temperature, then a volume of extract corresponding to 0?1 OD550
units was separated by electrophoresis in a 12% SDS-polyacrylamide
Fig. 1. Diagram of TetA(B) tetracycline/H+ antiporter. TM a-
helices are indicated by rectangles numbered 1–12. Amino
acid residues of the interdomain loop are shown. Black circles,
residues studied with list of substitutions introduced; white
circles, secondary-site suppressor of Ser201Cys mutant; bold
type, selected residues important for tetracycline resistance
and substrate specificity; Ia, a-helix in the interdomain loop
(boxed).
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gel (Sambrook & Russell, 2001) using a Miniprotein II gel apparatus
(Bio-Rad), and the proteins were then transferred electrophoretically
to a PolyScreen polyvinylidene difluoride membrane (Perkin Elmer
Life Sciences) using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-
Rad) according to the manufacturer’s recommendations. Western
blot analysis was performed according to Sambrook & Russell
(2001) with blocking by 0?5% bovine serum albumin, with the
exception that the detergent Tween 80 was used instead of Tween
20. Immunological detection was carried out with polyclonal anti-
bodies directed against the 14 carboxyl-terminal (Ct) amino acids of
TetA(B) (anti-Ct antibody, kindly provided by A. Yamaguchi)
(Yamaguchi et al., 1990a). The antigen–antibody complexes were
detected with horseradish peroxidase coupled to anti-rabbit IgG
(New England Biolabs). Blots were developed with the Western
Lighting Chemiluminescence Reagent Plus kit (Perkin Elmer Life
Sciences) and exposed to Kodak BioMax Light Film.
RESULTS AND DISCUSSION
Effect on tetracycline resistance of substitution
at Asp190 with Glu, Asn, Ala or Cys
The cytoplasmic interdomain loop of TetA(B) extends from
aa 179 to 213 and connects TM6 to TM7 (Fig. 1). It pos-
sesses two aspartate residues which are located in the first
third of the loop. By cysteine-scanning mutagenesis of the
loop, Yamaguchi and his coworkers (Tamura et al., 2001)
showed that a cysteine substitution for aspartate at position
190 reduces tetracycline resistance. To evaluate the amino
acid requirements for normal function at this position,
we replaced this negatively charged aspartate residue with
three other amino acids: Glu (negatively charged), Asn
(uncharged and similar size) and Ala (small and hydro-
phobic). We also independently recreated the Asp190Cys
mutation. All four site-directed substitutions were intro-
duced into tetA(B) by a PCR overlap method using two
primers (see Methods). The levels of tetracycline resistance
conferred by the single substitutions are presented in
Table 2 (column 3). The Asp190Glu substitution (which
retained a negative charge) showed only a slight reduction of
tetracycline resistance, whereas the replacement of Asp190
with Asn, Ala or Cys decreased the tetracycline resistance by
3?4-, 4?4- and 12-fold, respectively. The results indicate that
the negative charge allows near wild-type expression of
resistance, while other residues are only partially functional.
The level of protein production (Fig. 2a) showed that the
changes in resistance were not attributable to a variation in
the expression of the protein. Therefore, the TetA(B) pro-
tein can accommodate various amino acids at Asp190 since
in every mutant studied some activity was still remaining;
however, retention of the negative charge provided the best
tetracycline resistance activity.
Effect of substitution on tetracycline resistance
at Glu192 with Asp, Gln, Ala or Cys
TetA(B) possesses 10 glutamate residues which are equally
distributed in loops protruding in the cytoplasmic and
periplasmic space. Three of them, Glu181, Glu192 and
Glu206, are located in the interdomain loop; of these three
only Glu192 showed some role in tetracycline resistance as
demonstrated by cysteine-scanning mutagenesis (Tamura
et al., 2001). The same mutagenic method used above was
applied to construct four single substitutions (Asp, Gln, Ala
and Cys) at Glu192. The Glu192Asp substitution had little
effect on tetracycline resistance; thus a good level of activity
could be maintained when the negative charge was retained.
The replacement of Glu192 with Gln, Ala or Cys decreased
tetracycline resistance by 3-, 4?2- and 8?7-fold, respec-
tively. The reduced tetracycline MICs were not due to a
lower expression of the protein as confirmed by Western-
immunoblot analysis (Fig. 2b).
The pattern of MIC values for the different Glu192 sub-
stitutions was identical to that for the Asp190 replacements.
In both cases, retention of negative charge was optimal,
while the other changes similarly reduced, but never
completely eliminated activity, with Cys giving the most
drastic reduction.
Table 1. Primers used for site-directed mutagenesis
Two primers, corresponding to the sense and antisense sequence of the tetA(B) gene, were used to create each mutation. The second muta-
genic primer (not shown) was the reverse complement of the first. The mutated codon is in lower case. Mismatches are indicated in bold
letters and newly created restriction sites are underlined.









Ser201Ala GAGACGCAATCGAATgcgGTATACATCACTTTA Loss of EcoRI
Ser201Thr GAGACGCAATCGAATacgGTATACATCACTTTA Loss of EcoRI
Leu9Phe ACAAAGATCGCAtttGTGATCACGTTACTCGATGC BclI
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Effect of substitution on tetracycline resistance
at Ser201 with Thr, Ala or Cys
The plasmid bearing the Ser201Cys mutation (Kimura
et al., 1997) was obtained from A. Yamaguchi. The two
additional substitutions chosen were Ala (small and
hydrophobic) and Thr (conservative mutation that main-
tains the hydroxyl group of Ser). The Ala and Thr
substitutions of Ser201 each lowered the tetracycline
MIC by only 1?3-fold (Table 2). Therefore, a hydroxyl
group at position 201 is not obligatory for tetracycline
resistance function, nor does the residue need be hydro-
philic. As expected, the Cys mutation reduced tetracycline
resistance by 4?8-fold (Table 2).
Effect of various substitutions at Asp190,
Glu192 and Ser201 and a second-site
Ser201Cys suppressor mutation on substrate
specificity
To assay whether a region of TetA(B) is involved in
tetracycline binding, one may ask if amino acid substitu-
tions in that region change the specificity of the pump for
Table 2. Susceptibility to tetracycline and tetracycline analogues by wild-type and mutant TetA(B) proteins
WT-TetB, No mutation; Dox, doxycycline; Min, minocycline; Tet, tetracycline. Numbers in bold differ by more than 1?5-fold from the
control strain WT-TetB.
Mutation Mutation location MIC (mg ml”1)* Ratio Dox/TetD Ratio Min/TetD
Tet Dox Min
WT-TetB 128 32 16 1 1
Asp190Cys Interdomain loop 11 14 8 5?3 6?2
Asp190Asn Interdomain loop 37 28 16 3?0 3?5
Asp190Ala Interdomain loop 29 20 12 2?7 3?3
Asp190Glu Interdomain loop 117 32 16 1?1 1?1
Glu192Cys Interdomain loop 15 16 10 4?4 5?6
Glu192Gln Interdomain loop 43 32 16 3?0 3?0
Glu192Ala Interdomain loop 31 14 12 1?8 3?1
Glu192Asp Interdomain loop 117 28 16 0?9 1?1
Ser201Cys Interdomain loop 27 28 16 4?3 4?9
Ser201Ala Interdomain loop 96 32 14 1?3 1?2
Ser201Thr Interdomain loop 96 32 14 1?3 1?2
Leu9Phe TM1 75 24 12 1?3 1?3
Leu9Phe/Ser201Cys TM1 and interdomain loop 96 24 12 1?0 1?0
Gly20Cys TM1 32 12 3 1?4 0?6
Asn184Cys Interdomain loop 96 24 14 1?0 1?2
Thr191Cys Interdomain loop 96 24 12 1?0 1?0
Val339Cys TM11 80 16 7 0?8 0?7
Gly366Cys Periplasmic loop 11–12 80 24 12 1?2 1?2
No plasmid – 0?75 1?25 0?63 – –
*Mean MIC values of three separate experiments obtained by the E-test method (see Methods).
DMIC of control cells was subtracted before calculation of ratios. Ratios are normalized to WT-TetB=1.
Fig. 2. Western blot analysis of wild-type and mutated TetA(B)
proteins. Proteins from total-cell lysates were separated by
SDS-PAGE, electroblotted and probed with anti-Ct antibody.
(a) Asp190 substitutions; (b) Glu192 substitutions; (c) Ser201
substitutions and second-site suppressor of Ser201Cys.
Arrows indicate the position of the 36 kDa Tet protein. WT,
Wild-type.
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different tetracycline analogues. For the wild-type and
mutant proteins, we therefore compared the resistance to
tetracycline with that to two other analogues, doxycycline
and minocycline (Table 2). We noted that no resistance was
offered by any of the mutants to 9-(t-butylglycylamido)-
minocycline (data not shown), a glycylcycline used in
previous studies (Tuckman et al., 2000). The data are
presented as the ratio of the MIC for the analogue to the
MIC for tetracycline, which was then normalized to that for
the wild-type.
The substitutions at Asp190 and Glu192 with Cys, Ala and
Asn or Gln primarily altered tetracycline resistance with-
out affecting analogue resistance (except Asp190Cys). The
effect led to a 1?8- to 6?2-fold preference for doxycycline/
minocycline over tetracycline relative to the wild-type pump
(Table 2) and so altered substrate specificity. Only those
substitutions that have greater than a 1?5-fold effect were
considered as having altered the substrate specificity. Of
note, retention of the negative charge at Asp190 and Glu192
restored tetracycline resistance, removing the preference
for doxycycline and minocycline over tetracycline.
At position Ser201, substitution with Ala or Thr had no
effect on specificity. However, substitution with Cys led
to a 4?3- to 4?9-fold relative preference for doxycycline/
minocycline. Again, this altered specificity can be seen as a
loss in tetracycline resistance and not in analogue resistance,
when compared to wild-type (Table 2).
Since the inactivating Ser201Cys substitution of class B is
at a position similar to that of the inactivating Ser202Phe
mutation of class C (Saraceni-Richards & Levy, 2000a), we
examined whether the former would be suppressed by
Leu9Phe, which corresponds to the Leu11Phe in TM1 which
suppresses the class C mutation (Sapunaric & Levy, 2003).
The Leu9Phe replacement indeed suppressed the Ser201Cys
mutation, restoring a nearly wild-type level of tetracycline
resistance; the Leu9Phe replacement by itself had little effect
on TetA(B) function (Table 2). It is therefore possible that
this secondary suppressor mutation modifies the structure
of TM1, which in turn corrects the interdomain region that
had been inactivated by the Ser201Cys mutation. The sub-
strate specificity effect of 201Cys is suppressed by Leu9Phe,
by restoring the tetracycline resistance (Table 2).
We conclude that retention of the negative charge at resi-
dues Asp190 and Glu192 did not affect substrate specificity.
If the replacement at residues 190 and 192 was uncharged,
but retained the same size, the specificity was somewhat
altered. If the replacement was smaller (Ala or Cys), a more
dramatic specificity shift occurred. At position Ser201, sub-
stitutions of a similar size had no effect, except for Cys. At all
three positions, replacement by Cys caused the most drastic
shift in specificity towards the analogues. Since doxycycline
and minocycline are both more lipophilic than tetracycline
(Barza et al., 1975), all of the specificity-altering substitu-
tions may somehow reduce the ability of the protein to
handle hydrophilic substrates.
To further demonstrate that the substrate specificity effects
attributed to the mutations at Asp190, Glu192 and Ser201
of TetA(B) were meaningful, we chose as ‘controls’ four
cysteine mutants which significantly lowered activity of
TetA(B) according to Tamura et al. (2001): Gly20Cys,
Val339Cys, Gly366Cys and Asn184Cys. We also intention-
ally chose the Thr191Cys mutant for its strategical position
between Asp190 and Glu192 as another ‘control’ (Tamura
et al., 2001). The single cysteine mutations on a low-copy-
number plasmid were provided by A. Yamaguchi and their
tetracycline MICs were consistent with those reported pre-
viously (Kimura-Someya et al., 2000; Konishi et al., 1999;
Tamura et al., 2001). For each single cysteine mutant, the
MICs and the ratio of the MIC for the two analogues to
the MIC for tetracycline showed a proportional decrease
in resistance to both tetracycline and to the analogues in
all cases (see Table 2). None of the five cysteine ‘control’
mutations provided a change of substrate specificity towards
the tetracycline analogues tested. We conclude that Asp190,
Glu192 and Ser201 in the interdomain cytoplasmic loop
all appear to be involved in substrate specificity and there-
fore are likely to interact with the substrate.
The substrate for TetA is a tetracycline–divalentmetal cation
complex with a net charge of+1 (Yamaguchi et al., 1990b,
1991). That the negative charge of Asp190 and Glu192 is
not essential (Table 2) suggests that these residues may
not interact directly with the Mg2+ region of the substrate.
Moreover, substitutions at the three positions cause a
greater loss in activity towards tetracycline than towards the
lipophilic analogues, which also utilize Mg2+.
Other negative residues located in TMs and loops of
TetA(B) that are important for activity have been iden-
tified previously. The negative charge held by Asp15 (TM1)
(McMurry et al., 1992; Yamaguchi et al., 1992b), Asp66
(loop 2-3) (Yamaguchi et al., 1992b), Asp84 (TM3)
(Yamaguchi et al., 1992b) and Asp285 (Yamaguchi et al.,
1992b), were shown to be important for transport activity.
For Asp15 and Asp84, helical projections and cysteine-
scanning mutagenesis demonstrated that both residues are
oriented towards the putative central water-filled channel
and may be a part of the translocation pathway of tetracy-
cline (Tamura et al., 2001). Asp66 is located in the conserved
sequence motif, GXXXXRXGRR, of cytoplasmic loop 2-3,
which was postulated to be a part of the entrance gate of
the tetracycline divalent cation complex (Yamaguchi et al.,
1992a, 1990c). In contrast with the previous negatively
charges residues, Asp285, located in the TM9, is essential for
TetA(B) activity (Yamaguchi et al., 1992b) and cannot be
replaced even with glutamate (Yamaguchi et al., 1992b).
Other residues involved in substrate specificity in TetA(B)
are Gly111Glu (TM4), Trp231Cys and Trp231Gly (TM7),
Leu253Phe (TM8) and Leu308Ser (TM10) (Fig. 1) all of
which increase the resistance to 9-(dimethylglycylamido)-
minocycline and tigecycline GAR936 (Guay et al., 1994;
Tuckman et al., 2000). Since these mutations lie in or
near regions which probably face the putative water-filled
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channel (see Tamura et al., 2001), the different substitutions
may introduce a conformational change in their respective
TM so as to preferentially affect the binding and/or trans-
location pathway of the tetracycline analogues.
In LacY, another member of major facilitator superfamily,
the interdomain loop affects the insertion and stability of
the protein into the membrane, but has not been impli-
cated in substrate binding (Weinglass & Kaback, 2000).
Hydrophilic residues within the interdomain loop of LacY
are required to permit a temporal delay for the insertion of
both domains. In TetA(B), the cytoplasmic interdomain
loop is more than a linker between the a and b domains
since mutations in it affect resistance (Sapunaric & Levy,
2003; Saraceni-Richards & Levy, 2000a). We have shown
here that this loop also possesses at least three residues that
appear to be involved in interacting with the tetracycline/
Mg2+ substrate.
Structural analysis of the interdomain loop of
tetracycline efflux pumps
The crystal structure of two transporters belonging to the
major facilitator superfamily, the E. coli lactose permease
(LacY) and the glycerol 3-phosphate transporter GlpT were
solved at 3?5 and 3?3 A˚ respectively (Abramson et al., 2003;
Huang et al., 2003). In addition to their 12 TM segments,
secondary structures were revealed in both interdomain
loops. No function has been attributed to it, but stability of
the protein appears linked to the interdomain loop of LacY
(Weinglass & Kaback, 2000). Since the interdomain loop
has no homology among the related TetA proteins, it is
surprising that it appears to play a part in binding to
substrate. We reasoned that secondary structure might be
present in the loop region of all TetA proteins.
Using PSIPred, a computational tool from University
College London, that predicts secondary structure (Jones,
1999; McGuffin et al., 2000), we analysed the secondary
structure of the interdomain loop of 14 TetA efflux pump
homologues. We used the 3D structure of LacY and GlpT
(Abramson et al., 2003; Huang et al., 2003) as controls to test
the validity of the prediction. The prediction from PSIPred
showed two short helical segments in the interdomain
cytoplasmic loop of LacY, in agreement with the resolved
structure (Fig. 3a). The degree of confidence for each of
the two helices is different, with a very high score for the
second structure of eight residues. The shorter one was
Fig. 3. Predicted secondary structure of the interdomain loop of tetracycline efflux TetA proteins from 14 different tetracycline
resistance determinants compared to known LacY and GlpT structures. (a) Secondary structure in LacY and GlpT and
predicted secondary structure in TetA efflux proteins. (b) Prediction of secondary structure in wild-type and in serine 201
substitution TetA(B) mutants. Ia, a-helix in the interdomain loop of TetA efflux protein (boxed). Arrows indicate positions
affecting substrate specificity in TetA(A) and TetA(B). *, Coordinates of start and end residues of the interdomain loop of LacY
and GlpT were determined in their 3D structure (Abramson et al., 2003; Huang et al., 2003); 3 , coordinates of the interdomain
loop of TetA(B) are based on cysteine-scanning analysis (Tamura et al., 2001); 4 , coordinates of the interdomain residues of
the TetA efflux determinants are derived from TetA(B) coordinates after ClustalW alignment of all the Tet efflux proteins.
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misinterpreted by one residue. The secondary structure
prediction for GlpT also proposes two short helices, one of
four amino acids, 219IEEY223, and one of seven residues,
242QIFMQYV248. The actual structure of GlpT has only
the second helix (Huang et al., 2003). The predicted first
short helix might be missing since it is adjacent to a dis-
ordered region from Asn232 to Leu239. Based on com-
parison of these predictions with the known structures, we
accepted a PSIPred value of ¢4 as indicating a good level
of confidence in predicting a secondary structure and,
moreover, that a difference between two successive values
equal or greater than 2 would put an end to the predicted
secondary structure. As can be noted, in almost all of
the tetracycline efflux pumps examined, a short a-helical
segment was predicted (Fig. 3a). The length of this
secondary structure varied from four to ten residues. This
new putative structured element of the interdomain loop
of tetracycline efflux proteins was named Ia (for inter-
domain a-helix). In only three tetracycline transporters
[Tet(Z), Tet(31) and Tet(33)] were no helix or other
secondary structures predicted in the interdomain loop. We
note that Tet(Z) and Tet(33) are closely related and, unlike
the other classes, come from Gram-positive organisms. For
TetA(A), two different sequences are shown in Fig. 3(a).
The first corresponds to the wild-type TetA(A) (GenBank
accession no. P02982) and the second sequence, TetA(A)(2),
is from a veterinary Salmonellaminocycline-resistant isolate
which diverges from the wild-type by three amino acid
changes in the interdomain loop (Tuckman et al., 2000).
This modification is accompanied by a change in substrate
specificity of the pump (Tuckman et al., 2000). The muta-
tions in TetA(A)(2) increase the length of the predicted Ia
by one residue and raise the level of confidence for the
entire segment.
For TetA of class A and C, the level of confidence is high for
the predicted Ia. These two proteins share high identity
(78%) over their full lengths. Moreover, they are the only
two classes that have extensive identity (68%) over their
interdomain loop. For class B, D and H, shorter secondary
structures were predicted with a lower level of confidence
[residues 202–206 for TetA(B)]. The sequences in helix Ia are
different for each of the TetA proteins.
We also analysed the effect of the different substitutions at
Ser201 in TetA(B), since this serine is at the border of the
predicted Ia. As can be seen in Fig. 3(b), each of the three
substitutions increased the length of the predicted Ia
structure by one or two residues. Another factor is that
residues 201, 203, 204, (and 211) of TetA(B), when changed
to Cys, were the only residues in the interdomain loop
inaccessible to a sulfhydral reagent (Tamura et al., 2001).
Thus, these four residues might be ‘occluded’, further sup-
porting the idea of an ordered secondary or tertiary struc-
ture covering this region. In the structures of both LacY and
GlpT, the longer Ia is at a similar position in the inter-
domain loop, although no function has been attributed to it
(Abramson et al., 2003; Huang et al., 2003). According to
the structural data of LacY (Abramson et al., 2003) and
of GlpT (Huang et al., 2003), this helix lies parallel to the
membrane surface near the cytoplasmic end of TM11.
Concluding remarks
Our data suggest that residues Asp190, Glu192 and Ser201
of the interdomain loop of TetA(B) interact with sub-
strate. The change of the substrate specificity caused by
single mutations depended on the nature of the substitu-
tion itself and was associated with an increased length of a
putative helical secondary structure Ia in the interdomain
loop of TetA(A) and TetA(B).
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